| Steven R Yolen, MD | |
|
45 Wells St, Suite 103, Westerly, RI 02891-2927 | |
| (401) 596-6330 | |
| (401) 348-0420 |
| Full Name | Steven R Yolen |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 42 Years |
| Location | 45 Wells St, Westerly, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376582692 | NPI | - | NPPES |
| 003108273 | Medicaid | CT | |
| 9021219 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD10338 (Rhode Island) | Primary |
| 207RG0100X | Internal Medicine - Gastroenterology | 026127 (Connecticut) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Westerly Hospital | Westerly, RI | Hospital |
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
| Northeast Medical Group Inc | 1254233836 | 1251 |
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
27 babies in Japan have been born virus-free after the virus was removed from the the sperm of HIV-positive fathers.
Cholesterol influences the health of our hearts and blood vessels. Conventional treatment attempts to reduce the level of "bad" cholesterol, LDL cholesterol, in the blood plasma. The opposite approach, which involves increasing the concentration of "good" HDL cholesterol using nicotinic acid, has proven unpopular among patients up to now. The reason for this is that treatment with nicotinic acid has an unpleasant but harmless side-effect: the drug makes patients turn quite red in the face. Scientists at the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now discovered the mechanism behind this effect, which is known as flushing. This will enable the development of flush inhibitors and thereby the more effective prevention of cardiovascular diseases.
Isotechnika Pharma Inc., a biopharmaceutical company focused on the discovery and development of immune modulating therapeutics, and 3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the signing of a development and commercialization agreement for voclosporin, a next generation calcineurin inhibitor being developed for use in the prevention of organ rejection following transplantation and the treatment of autoimmune diseases.
Renowned evolutionary researcher, Jesse Bloom from the Fred Hutchinson Cancer Research Center, has conducted a phylogenetic analysis suggesting that the early severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences that were obtained from the Huanan Seafood Market in Wuhan, China, are not fully representative of the viruses circulating in the city at the time of the coronavirus disease 2019 (COVID-19) outbreak.
› Verified 1 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
27 babies in Japan have been born virus-free after the virus was removed from the the sperm of HIV-positive fathers.
Cholesterol influences the health of our hearts and blood vessels. Conventional treatment attempts to reduce the level of "bad" cholesterol, LDL cholesterol, in the blood plasma. The opposite approach, which involves increasing the concentration of "good" HDL cholesterol using nicotinic acid, has proven unpopular among patients up to now. The reason for this is that treatment with nicotinic acid has an unpleasant but harmless side-effect: the drug makes patients turn quite red in the face. Scientists at the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now discovered the mechanism behind this effect, which is known as flushing. This will enable the development of flush inhibitors and thereby the more effective prevention of cardiovascular diseases.
Isotechnika Pharma Inc., a biopharmaceutical company focused on the discovery and development of immune modulating therapeutics, and 3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the signing of a development and commercialization agreement for voclosporin, a next generation calcineurin inhibitor being developed for use in the prevention of organ rejection following transplantation and the treatment of autoimmune diseases.
Renowned evolutionary researcher, Jesse Bloom from the Fred Hutchinson Cancer Research Center, has conducted a phylogenetic analysis suggesting that the early severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences that were obtained from the Huanan Seafood Market in Wuhan, China, are not fully representative of the viruses circulating in the city at the time of the coronavirus disease 2019 (COVID-19) outbreak.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven R Yolen, MD 45 Wells St, Suite 103, Westerly, RI 02891-2927 Ph: (401) 596-6330 | Steven R Yolen, MD 45 Wells St, Suite 103, Westerly, RI 02891-2927 Ph: (401) 596-6330 |
News Archive
27 babies in Japan have been born virus-free after the virus was removed from the the sperm of HIV-positive fathers.
Cholesterol influences the health of our hearts and blood vessels. Conventional treatment attempts to reduce the level of "bad" cholesterol, LDL cholesterol, in the blood plasma. The opposite approach, which involves increasing the concentration of "good" HDL cholesterol using nicotinic acid, has proven unpopular among patients up to now. The reason for this is that treatment with nicotinic acid has an unpleasant but harmless side-effect: the drug makes patients turn quite red in the face. Scientists at the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now discovered the mechanism behind this effect, which is known as flushing. This will enable the development of flush inhibitors and thereby the more effective prevention of cardiovascular diseases.
Isotechnika Pharma Inc., a biopharmaceutical company focused on the discovery and development of immune modulating therapeutics, and 3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the signing of a development and commercialization agreement for voclosporin, a next generation calcineurin inhibitor being developed for use in the prevention of organ rejection following transplantation and the treatment of autoimmune diseases.
Renowned evolutionary researcher, Jesse Bloom from the Fred Hutchinson Cancer Research Center, has conducted a phylogenetic analysis suggesting that the early severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences that were obtained from the Huanan Seafood Market in Wuhan, China, are not fully representative of the viruses circulating in the city at the time of the coronavirus disease 2019 (COVID-19) outbreak.
› Verified 1 days ago
Robert E Fox, MD Gastroenterology Medicare: May Accept Medicare Assignments Practice Location: 268 Post Rd, Suite 203, Westerly, RI 02891 Phone: 401-604-2530 Fax: 401-604-2560 | |
Dr. James G Stuart, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 46 Wells Street, Westerly, RI 02891 Phone: 401-596-0174 Fax: 401-596-2266 | |
Mr. Christopher A. D'arcy, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 45 Wells Street, Suite 203b, Westerly, RI 02891 Phone: 401-348-2180 Fax: 401-348-6298 | |
Joseph R Dotolo, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 27 Crestview Dr, Westerly, RI 02891 Phone: 401-596-2277 Fax: 401-596-6140 | |
Dr. Stephen M Kutz, M.D., FACC Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 45 Wells St, Suite 102, Westerly, RI 02891 Phone: 401-596-4499 Fax: 401-596-6360 | |
Vindhya Bharathi Sriramoju, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 45 Wells St Ste 102, Westerly, RI 02891 Phone: 401-596-4499 | |
Peter E. Bolton, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 77 Franklin St, Westerly, RI 02891 Phone: 401-596-6464 Fax: 401-348-8660 |